AU6217773A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
AU6217773A
AU6217773A AU62177/73A AU6217773A AU6217773A AU 6217773 A AU6217773 A AU 6217773A AU 62177/73 A AU62177/73 A AU 62177/73A AU 6217773 A AU6217773 A AU 6217773A AU 6217773 A AU6217773 A AU 6217773A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU62177/73A
Other versions
AU467532B2 (en
Inventor
David Harden
Henry J. Kessler
Allan J. Torode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU6217773A publication Critical patent/AU6217773A/en
Application granted granted Critical
Publication of AU467532B2 publication Critical patent/AU467532B2/en
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62177/73A 1972-11-06 1973-11-05 Pharmaceutical formulations Expired AU467532B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations
GB51050/72 1972-11-06

Publications (2)

Publication Number Publication Date
AU6217773A true AU6217773A (en) 1975-05-08
AU467532B2 AU467532B2 (en) 1975-12-04

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62177/73A Expired AU467532B2 (en) 1972-11-06 1973-11-05 Pharmaceutical formulations

Country Status (14)

Country Link
JP (1) JPS577127B2 (en)
AU (1) AU467532B2 (en)
BE (1) BE806946A (en)
CA (1) CA975297A (en)
CH (1) CH583734A5 (en)
CY (1) CY940A (en)
DE (1) DE2355204A1 (en)
FR (1) FR2205309B1 (en)
GB (1) GB1445983A (en)
HK (1) HK1278A (en)
IL (1) IL43562A (en)
KE (1) KE2807A (en)
MY (1) MY7800180A (en)
ZA (1) ZA738489B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (en) * 1986-12-12 1990-03-02 Chauvin Laboratoires USE OF XANTHINE OXIDASE INHIBITORS, OXYGEN FREE RADIAL TRAPERS AND IRON CHELATORS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
CY940A (en) 1978-06-23
KE2807A (en) 1978-02-17
CH583734A5 (en) 1977-01-14
AU467532B2 (en) 1975-12-04
DE2355204A1 (en) 1974-05-16
FR2205309B1 (en) 1976-04-09
JPS49133517A (en) 1974-12-21
CA975297A (en) 1975-09-30
HK1278A (en) 1978-01-13
JPS577127B2 (en) 1982-02-09
IL43562A0 (en) 1974-03-14
GB1445983A (en) 1976-08-11
ZA738489B (en) 1975-02-26
BE806946A (en) 1974-05-06
IL43562A (en) 1976-08-31
MY7800180A (en) 1978-12-31
FR2205309A1 (en) 1974-05-31

Similar Documents

Publication Publication Date Title
CA987587A (en) Dietary formulations
AU472941B2 (en) Pharmaceutical compositions
AU475493B2 (en) Pharmaceutical formulations
CA977503A (en) Rinse-wax formulation
AU475599B2 (en) Pharmaceutical compositions
AU3701671A (en) Pharmaceutical formulations
AU476390B2 (en) Pharmaceutical composition
AU467532B2 (en) Pharmaceutical formulations
AU5915973A (en) Pharmaceutical compositions
CA986412A (en) Iodophor-steroid pharmaceutical compositions
CA1006816A (en) Pharmaceutical compositions
CA910816A (en) Parasiticidal wax-starch formulations
AU476456B2 (en) Pharmaceutical preparation
AU472192B2 (en) Pharmaceutical compositions
CA892542A (en) Pharmaceutical compositions
CA910906A (en) Pharmaceutical compositions
CA907516A (en) Pharmaceutical compositions
CA899777A (en) Pharmaceutical compositions
CA896528A (en) Pharmaceutical compositions
AU474663B2 (en) Pharmaceutical compositions
CA894211A (en) Pharmaceutical compositions
CA900356A (en) Pharmaceutical compositions
AU478574B2 (en) Pharmaceutical composition
CA900357A (en) Pharmaceutical composition
CA907518A (en) Medicinal compositions